Cargando…
Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer
OBJECTIVE: Resistance to chemotherapeutic drugs, such as cisplatin, has been one of the major problems adversely affecting the clinical prognosis of patients with gastric cancer (GC). Disabled Homolog 2-Interacting Protein (DAB2IP) status is one of the major factors involved in sensitivity to chemot...
Autores principales: | Wang, Guannan, Wang, Xu, Han, Meng, Wang, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884952/ https://www.ncbi.nlm.nih.gov/pubmed/33603402 http://dx.doi.org/10.2147/OTT.S289722 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer
por: Shen, Yi-Jun, et al.
Publicado: (2014) -
Smurf1 regulation of DAB2IP controls cell proliferation and migration
por: Li, Xiaoning, et al.
Publicado: (2016) -
DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway
por: Sun, Liang, et al.
Publicado: (2018) -
Erratum to “DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway”
por: Sun, Liang, et al.
Publicado: (2020)